ADENOSINE A3 RECEPTOR AGONISTS FOR THE TREATMENT OF DRY EYE DISORDERS INCLUDING SJOGREN'S SYNDROME

ADENOSINE A3 RECEPTOR AGONISTS FOR THE TREATMENT OF DRY EYE DISORDERS INCLUDING SJOGREN'S SYNDROME

A method for treating and/or preventing Sjogren syndrome, comprising administrating to the individual an A3 adenosine receptor agonist (A3RAg). The A3RAg may be administered either topically or orally.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FISHMAN, PNINA, LORBER, ILANA, COHN, ILAN, REITBLAT, TATIANA
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A method for treating and/or preventing Sjogren syndrome, comprising administrating to the individual an A3 adenosine receptor agonist (A3RAg). The A3RAg may be administered either topically or orally.